In both women and men
In women
In men
Chronic pelvic pain (CPP)a
Urethral syndromea
Chronic prostatitis/prostatodyniaa
Perineal paina
Urinary retention
Orchialgia (testicular pain)a
Perianal paina
Overactive bladdera
Penile paina
Sexual dysfunctiona
Interstitial cystitis (IC)a
Ejaculatory pain or obstructiona
Voiding dysfunction
Urinary tract infections
Obstructive voiding (“prostatism”)a
Urinary urgency
Vaginal infections
Frequent urination
Dyspareuniaa
Obstructive defecation
Vulvodyniaa
Constipationa
Vestibulodynia
Irritable bowel syndrome (IBS)a
Vaginismus
Proctalgia fugax
Sexual arousal disordera
Anismus
Orgasmic paina
Anal fissuresa
Pelvic congestiona
Hemorrhoidsa
Coccygodyniaa
Varicocelea
Low back paina
Hyperventilationa
In a 2005 report from the Pelvic Floor Clinical Assessment Group of the International Continence Society (ICS), the term “OAPF muscles” was defined as a condition “in which the pelvic floor muscles do not relax, or may even contract when relaxation is functionally needed, for example during micturition or defecation” [35]. A diagnosis of OAPF is based on both symptoms (subjective complaints) such as voiding problems, obstructed defecation, or dyspareunia, and on signs observable upon physical examination, like the absence of voluntary pelvic floor muscle relaxation [35]. Van Lunsen and Ramakers proposed a similar but broader definition for the HPFS [23]. Based on a review of the available scientific data and on clinical observations, the authors proposed three diagnostic criteria for HPFS: (a) comorbidity of three or more symptoms known to be associated with pelvic floor dysfunction (see Table 1.1); (b) evidence of pelvic floor dysfunction based on physical pelvic floor assessment and/or functional tests; and (c) comorbidity of one or more sources of psychological distress [23]. Although these exact diagnostic criteria have not been validated to date, they highlight the need to adopt a biopsychosocial perspective and a multidisciplinary approach in the clinical diagnosis and treatment of OAPF.
Another issue that appears to have perpetuated the lack of a clear definition for OAPF is an apparent general misunderstanding of what constitutes and differentiates skeletal muscle tone from muscle activity. Terms related to an increase in muscle tone (e.g., hypertonicity, hypertonia) have often been used synonymously with, or instead of, terms to designate a state of elevated muscular activity (e.g., overactivity, hyperactivity ). This has led to the common misconception that heightened muscle tone is the direct result of elevated muscle activity and that the two physical states are equivalent. A discussion of the distinction between muscle tone and muscle activity is presented below because this knowledge is essential for understanding the pathophysiological processes potentially underlying the development and maintenance of OAPF, and associated symptoms and conditions.
1.3.1 “Muscle Tone” versus “Muscle Activity”
Muscle tone, commonly referred to as muscle tension, is measured as stiffness; the change in resistance or force per unit change in length (∆force/∆dist ance) [18]. Clinically, the tone/stiffness of the pelvic floor muscles is assessed through palpation as the resistance felt when a passive stretch is applied to the muscles [36, 37]. In a normally innervated skeletal muscle, muscle tone comprises both passive (viscoelastic) and active (contractile) components [18]. Muscle activity is an active component of muscle tone and refers to the electrical activity generated by muscle fibers when the motor unit is active and propagation of action potentials is detectable by electromyography (EMG) [18]. The muscular contraction resulting from muscle activity (i.e., electrogenic contraction) contributes to muscle tone. During the measurement of muscle tone, close monitoring of EMG recordings can help identify the presence and relative contribution of electrogenic contraction. Both normal and abnormal electrogenic contraction (i.e., detectable by EMG) can occur [18]. Normal electrogenic contraction refers to contractile activity that occurs in a normal muscle because it is not completely relaxed, but can be controlled voluntarily, or due to reflex activation (e.g., myotactic stretch reflex) [18, 38]. On the other hand, muscle spasm is defined as an abnormal/pathological (involuntary) electrogenic contraction that may or may not be painful [18]. In the context of healthy normally innervated skeletal muscle, a muscle cramp can be considered to be a form of muscle spasm [18]. The pain associated with muscle spasm/cramp may be caused by the shearing forces between the “cramping” and normal (not cramping) parts of the muscle [18, 39]. In addition, pain can also occur if the muscle becomes ischemic and releases pain-producing substances, which can occur if the muscle contracts forcefully for too long, and compresses its own blood vessels [18]. Although the assessment of muscle spasm alone is challenging, its possible contribution to muscle tone must be acknowledged.
Endogenous contracture, defined as a contractile state within a muscle that is not accompanied by electrical activity (i.e., no EMG activity is detected) [18], is also considered to be an active component of muscle tone. In normal muscle, palpable taut bands that are often associated with myofascial trigger points (i.e., hypersensitive/painful spots found within the taut bands of muscle) [40], which are the hallmarks of myofascial pain syndromes, have been suggested to represent a form of endogenous muscle contracture [18]. Taut bands, within otherwise relaxed muscles, are devoid of action potentials (i.e., EMG-silent) although trigger points have been found to exhibit electrical activity at their loci [18]. To date, there is no conclusive evidence regarding the pathogenesis of trigger points and taut bands although research supports more local factors such as focal ischemia and the associated release of various biochemical substances rather than central processes [18, 38, 41]. Spinal cord mechanisms, however, are thought to mediate pain referral and local twitch responses associated with trigger points [42], and sensitization of central pain pathways is thought to play an important role in the conversion of episodic myofascial pain arising from taut bands and trigger points, to more chronic pain states [43]. It has also been suggested that muscle spasm can induce the development of trigger points, and vice versa [18]. Although trigger points and taut bands can be detected with palpation [40], their exact contribution to muscle tone, as with muscle spasm, is difficult to measure.
1.3.2 “Hypertonic” versus “Overactive” Pelvic Floor Muscles
In a healthy skeletal muscle, an increase in muscle activity/EMG usually results in an increase in muscle tone due to the tension built-up from the contraction of muscle fibers. Hypertonic pelvic floor muscles, however, are not necessarily overactive. Muscle hypertonicity is a general increase in muscle tone that can be associated with either elevated contractile activity and/or viscoelastic stiffening in the muscle [18, 38] and may exist in the absence of muscle activity altogether. Figure 1.1 illustrates possible sources of muscle hypertonicity (measured as increased stiffness) in a normally innervated skeletal muscle.
Several passive (viscoelastic) structures are thought to contribute to the tone of skeletal muscles, including: the cross-bridges between the sarcomeric contractile proteins actin and myosin [44, 45], the extensibility of actomyosin filaments themselves [46, 47], the non-contractile proteins of the sarcomeric cytoskeletons (titin and desmin) and their filamentous connections [48–50], as well as the connective tissues (fascia) linking and covering muscle tissue [51–54]. An increase in muscle stiffness may occur due to changes in any of these passive structures, and in the absence of any detectable EMG. Both an increase (hypertrophy) and a decrease (atrophy) in a muscle’s size and mass are associated with increased muscle stiffness due to physiological adaptations of viscoelastic structures [51]. Since the sarcomeric proteins actin, myosin, titin, and desmin all reside within the muscle tissue itself, the increased stiffness that results from muscle hypertrophy [55] has been attributed in part to increases in these subcellular components [51]. Conversely, an increase in muscle stiffness seen with muscle atrophy due to disuse/immobilization is considered to primarily result from an accumulation and increased relative proportion of connective (fibrous) tissue within and surrounding the muscle [51]. Additionally, tissue adhesions (scars) resulting from injury to the muscle may also increase the viscoelastic stiffness of the muscle.
Although by definition OAPF implies a physical state of heightened activity within the pelvic floor muscles, individuals with OAPF are also commonly found to present with pelvic floor muscle hypertonicity from other sources, most notably myofascial trigger points [24, 31, 56], which are not associated with any detectable EMG. Emerging research also suggests that pelvic floor muscle hypertonicity in populations with OAPF symptoms and associated conditions may be in part due to changes in the muscles’ viscoelastic properties [57, 58]. Understanding and recognizing the various potential sources of pelvic floor muscle hypertonicity is particularly important for identifying the specific pelvic floor impairments affecting individuals with OAPF, and designing tailored treatment interventions; for example, in the case of physiotherapy, deciding whether to emphasize pelvic floor muscle awareness, control and relaxation exercises, and/or manual stretches and trigger point release techniques. In many cases, it is likely that OAPF symptoms are associated with various components of pelvic floor muscle hypertonicity and dysfunction, and a comprehensive treatment program involving a number of different techniques and strategies is usually applied to target all levels of dysfunction [32, 56, 59–61].
The relationships between the different sources of muscle tone (active and passive), and their contribution to muscle hypertonicity, remain under investigation. Although speculative, it is possible that in some cases there is a sequential pattern to the relative contribution of different elements to muscle hypertonicity. For example, a persistent lack of muscle relaxation and/or heightened (but “normal”) muscular activity may lead to involuntary muscle contraction (spasm), which may develop further into a myofascial pain syndrome involving taut bands and trigger points. Subsequently, the lack of movement/disuse of the muscles can lead to adaptive changes in their passive structures and result in viscoelastic stiffening. Given that the etiology of OAPF is poorly understood, the existence of relationships between the different components of muscle tone and a possible chronological nature to the development of muscle hypertonicity could be helpful in advancing knowledge on the pathogenesis of OAPF, as well as the duration and severity of impairments. Further research, however, is needed to elucidate these concepts, which for now remain hypothetical.
1.3.3 “Unnecessary” Muscle Tension/Activity
Of high relevance to the topic of OAPF, is the concept of “unnecessary” muscle tension [18]. In addition to the aforementioned active and passive components of muscle tone, Simons and Mense proposed that a type of muscular activity that is unintentional, but that is not a “spasm,” exists and is the source of what is often referred to clinically as “muscle tension” [18]. These authors note that this unnecessary/unintentional muscle activity, which is amenable to voluntary control with training (e.g., through biofeedback assistance), may arise from psychological distress or anxiety, overload from sustained contraction or repetitive activity, and/or inefficient use of muscles [18]. These sources of increased muscular activity, as they may pertain to OAPF, are discussed later in this chapter.
1.4 Etiology of the OAPF
OAPF may well be “the organic substrate causing both different kinds of urethral, vaginal, and anal outlet obstruction and different kinds of [genital/pelvic] pain as well as sexual dysfunctions ” [23]. According to Van Lunsen and Ramakers this is supported by empirical evidence, including research demonstrating the effectiveness of physiotherapy interventions aimed at improving pelvic floor muscle relaxation on symptoms of conditions associated with OAPF (e.g., vulvodynia, prostatodynia, dysfunctional voiding, constipation) [23]. The mechanisms underlying the onset of OAPF, however, are not fully understood.
The coexistence of different kinds of urinary, anorectal, and gynecological problems, sexual difficulties, genital/pelvic pain, and psychological distress in individuals with OAPF suggests that, as per its clinical presentation, the etiology of OAPF is likely multifactorial. OAPF is thought to occur as a “conditioned response to threat” [23], which may come in different forms. A variety of risk factors or etiological determinants have been proposed to explain the onset and maintenance of OAPF.
Pelvic pain, which refers to pain located anywhere in the genital, pelvic, and lower abdominal region, which may itself result from OAPF, is also considered to be the predominant cause of OAPF [24]. Pelvic pain has several possible origins and perpetuating factors, including physical injury or pathology affecting any biological tissue (musculoskeletal, neural, visceral) within the pelvic area or distant structures with pain referral patterns to this region, as well as psychological, psychosocial, and/or psychosexual distress [33, 62, 63], which in turn are also risk factors for the onset of OAPF. Additional potential triggers for the development of OAPF include abnormal patterns of pelvic floor muscle use, direct trauma and/or pathology, and postural abnormalities resulting from faulty postures, sustained positions, repetitive activities and/or skeletal asymmetries. Identifying the underlying cause(s) and perpetuating factors of OAPF, although often challenging, may be of significant importance when attempting to break the “vicious cycle” of ongoing pelvic dysfunction and pain experienced by affected individuals.
1.4.1 Chronic Pelvic Pain
Pain is defined as “an unpleasant sensory and emotional experience associated with actual or potential tissue damage, or described in terms of such damage” [64]. Chronic pain is typically defined as “non-malignant” pain that lasts longer than 6 months although duration is not a strict criterion [64]. Important evidence of chronic pain is that the pain is “out of proportion to any initiating pathology or the degree of tissue damage”, and is associated with significant psychological, emotional, behavioral, and environmental/social disturbances [65]. The neurophysiological basis for the multidimensional nature of chronic pain can be explained by the body-self neuromatrix described by Melzack [66], a neural network within the brain that integrates various inputs to produce the output of “pain”. Melzack explained that somatosensory, thalamocortical, and limbic components of the nervous system interact closely to form the “sensory-discriminative”, “evaluative-cognitive”, and “affective-motivational” dimensions of pain [66].
There is a very close relationship between OAPF and chronic pelvic pain (CPP). Although the mechanisms of association are not completely understood, pelvic floor muscle overactivity and hypertonicity have been found to be physical hallmarks of several different conditions involving CPP, including irritable bowel syndrome, (IBS), interstitial cystitis/bladder pain syndrome (IC/BPS), vulvodynia in women, and chronic prostatitis/prostatodynia in men [23–25, 67]. According to Diatchenko and colleagues [68], CPP is an “idiopathic pain disorder” (IPD) which, along with associated pelvic conditions (IBS, IC/BPS, and vulvodynia) and other non-pelvic conditions (such as fibromyalgia and chronic headaches), has two primary pathways of vulnerability that underlie its development. Such pathways include pain amplification and psychological distress and are both mediated by genetic and environmental/social factors [68]. Since CPP and OAPF are so intimately linked, a review of the mechanisms by which enhanced pain perception/pain amplification and psychological distress may occur and contribute to CPP may be useful for illustrating the possible etiological pathways through which OAPF may develop.
1.4.1.1 Neurophysiology of Pain
Pain begins with a noxious stimulus, an actual or potential tissue-damaging event that can be mechanical, chemical, or thermal [69]. Primary afferent fibers (thinly myelinated A-delta fibers and unmyelinated C-fibers from the skin and viscera, and group III and IV nerve fibers from the muscles and joints) transmit nociceptive signals from the periphery to the dorsal horn of the spinal cord where they synapse with interneurons, which mediate spinal reflexes, and with second-order neurons that transmit the nociceptive signals towards higher brain centers [69]. In the case of pelvic pain, the source of noxious input can be from any structure within the “sensory window of the pelvis” [70] (e.g., skin, bones, muscles, nerves, connective tissues, viscera), and as previously mentioned, also from structures outside of the pelvis that refer pain to the region.
Pain is not merely a stimulus–response process. Pain serves as an alarm system to the body, warning it of an actual or perceived threat of harm, and involves physiological processes within the body. The outcome of these processes, however, that is, whether a pain response occurs or not, is ultimately dependant on cognitive awareness and subjective appraisal [66]. As Hilton and Vandyken [71] noted, there is no such thing as “pain fibers” carrying “pain signals”; there are “nociceptive fibers” transmitting nociceptive or “danger signals” from the periphery to the brain. A noxious stimulus is only interpreted as “painful” once nociceptive information is integrated and processed within the brain, and the brain has decided that it is worth paying attention to. Otherwise, there is no pain response.
1.4.1.2 Neuropathophysiology of Chronic Pain
When noxious stimuli occur over a prolonged period of time, a series of processes occur within the peripheral and central nervous systems. The cumulative effect of these processes is the up-regulation of nociceptive system function, which leads to dysregulations in both the peripheral and central mechanisms of sensory and pain processing, and abnormal neuropathic output states [73]. A number of mechanisms are thought to be responsible for the up-regulation of nociceptive nervous system components.
Peripheral sensitization , which refers to the sensitization of peripheral nociceptors, is thought to occur mainly via the influence of biochemical/inflammatory mediators, which are released in response to ongoing noxious input [73]. As mentioned above, such an inflammatory response can occur in the absence of tissue damage [72]. The sensitization of peripheral nociceptors produces a reduction in their activation thresholds, causing increased firing responses to suprathreshold stimulation as well as spontaneous discharge [73]. Additional peripheral mechanisms that may contribute to the up-regulation of the nociceptive system include: (1) activation of “silent” nociceptive afferents, a special class of C-fibers that remain dormant under normal conditions but are activated by prolonged or highly noxious stimuli, and (2) conversion of myelinated afferents, such that they begin to act like nociceptive fibers [70, 73]. Ultimately, these changes within the peripheral nociceptive system contribute to increasing the noxious influx to the dorsal horn of the spinal cord.
Central sensitization involves a series of neuroplastic changes that occur in response to prolonged noxious stimuli, which result in the up-regulation (sensitization) of the dorsal horn of the spinal cord. The flooding of the dorsal horn by noxious input leads to biochemical and neuro-inflammatory events that can produce a reduction in the response thresholds of central neurons that process nociceptive signals and also enhance the signals transmitted by non-nociceptive afferents, such that they start contributing to pain perception [73].
Consequences of nociceptive system up-regulation and sensitization include “hyperalgesia,” defined as an increased response to a stimulus that is normally painful, and “allodynia,” which is pain due to a stimulus that does not normally provoke pain [64, 73], both of which have been found to be present in individuals with CPP [70, 74–78].
Of equal importance are the neuropathic output states that result from the up-regulation of the dorsal horn of the spinal cord [24, 73]. Since the main outcomes of central sensitization are increased synaptic efficacy and increased excitability of nociceptive central neurons within the dorsal horn, it is likely that these effects also influence the activity of other neurons with which they make synaptic connections [73]. This in turn leads to neuropathic reflexes, which are likely to underlie the sensorimotor and autonomic dysfunctions that occur in individuals experiencing chronic pain [73]. The first neuropathic reflex is known as “neurogenic inflammation” [70]. It involves a dorsal root reflex that causes afferent nerves to fire antidromically (backwards via the sensory peripheral nerve), leading to inflammation and hyperalgesia in the periphery [70]. Neurogenic inflammation and shared neural pathways between the pelvic viscera, known as pelvic organ “cross talk,” may be responsible for another neuropathic event known as “viscero-visceral hyperalgesia ” [70]. This phenomenon remains the primary explanation for the coexistence of various visceral CPP syndromes (e.g., IC, IBS, vulvodynia) [23, 24, 70]. In addition to the potential effect of dorsal horn up-regulation on alpha motor neuron excitability, a neuropathic reflex known as “viscero-muscular hyperalgesia” [24], which may involve the sensitization of muscle spindle afferents and increased excitability of gamma motor neurons, is thought to contribute to muscular instability and the development of myofascial trigger points [70, 73]. This neuropathic output state may, at least partly, explain how CPP may lead to OAPF [24, 70, 73].
1.4.2 Psychological Distress
Psychological distress and associated cognitive, emotional, and behavioral factors are thought to play a role in triggering and/or perpetuating CPP [79], and consequently OAPF. In acute/subacute states, pain acts to warn the body of actual or potential harm. However, when the threat is no longer present and an individual continues to perceive the pain that he/she is experiencing as threatening, processes are initiated that set the stage for the development of chronic pain. These processes form the fundamental components of the fear-avoidance model (FAM) of chronic pain , a widely accepted conceptual model that explains how negative pain-related cognitions and maladaptive behavioral responses contribute to the development and maintenance of chronic pain [79–82]. The ongoing appraisal of pain as threatening leads to “pain catastrophizing”, in which a person focuses on pain sensations and exaggerates the threat and intensity of pain [79, 81]. This in turn leads to the chief component of the FAM, namely “pain-related fear” [81]. The fear of pain, combined with pain-related anxiety and hypervigilance (i.e., heightened attention) to pain, leads to defensive behaviors, notably muscular reactivity/contraction, in the presence of a painful stimulus or in the anticipation of pain [81]. Ultimately, negative pain cognitions and behavioral responses to pain lead to escape and avoidance behaviors, which in turn lead to disuse, further perpetuating the “vicious cycle” of pain and dysfunction [79–82].